Odey Asset Management Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-3,400
Closed -$965K 73
2020
Q3
$965K Hold
3,400
0.13% 61
2020
Q2
$910K Hold
3,400
0.16% 56
2020
Q1
$1.08M Buy
+3,400
New +$1.03M 0.18% 56
2017
Q2
Sell
-4,000
Closed -$1.09M 65
2017
Q1
$1.09M Hold
4,000
0.11% 51
2016
Q4
$1.13M Buy
+4,000
New +$1.19M 0.12% 49

Other funds holding BIIB

Odey Asset Management Group's BIIB Position: Q4 2020 in Review

Odey Asset Management Group sold out of Biogen (BIIB) in Q4 2020, closing a stake of 3,400 shares — an estimated $965K sold.

Odey Asset Management Group first reported a position in BIIB in Q4 2016 and held it in 5 quarters. The position peaked at $1.13M in Q4 2016. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Odey Asset Management Group reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • Odey Asset Management Group sold 3,400 Biogen shares in Q4 2020, an estimated $965K.
  • Odey Asset Management Group first reported a position in Biogen in Q4 2016 and held it in 5 quarters.
  • Odey Asset Management Group's Biogen position peaked at $1.13M in Q4 2016.
  • 1,062 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Odey Asset Management Group's 13F filing for Q4 2020, filed 16 Feb 2021.